<DOC>
	<DOCNO>NCT01335347</DOCNO>
	<brief_summary>The purpose study demonstrate safety immunogenicity oral vaccine prevent avian influenza . Volunteers receive either one two dos research vaccine placebo part study .</brief_summary>
	<brief_title>Safety Study Oral Vaccine Prevent Avian Influenza</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Influenza Birds</mesh_term>
	<criteria>In good health establish medical history , physical examination laboratory test time enrollment . Has vaccine within past 8 week . Has prior H5 avian influenza investigational vaccine . Current history chronic alcohol consumption and/or illicit and/or recreational drug use . History autoimmune related disease . History confirm suspected immunodeficient immunosuppressive condition ( congenital acquire condition impedes normal immune response , concurrent immunosuppressive therapy ) . Positive serology HIV , HCV , HBV . Previous serious reaction vaccination anaphylaxis , respiratory problem , hive abdominal pain . History irritable bowel disease inflammatory digestive gastrointestinal condition could affect intend distribution safety evaluation orally administer vaccine target mucosa small intestine . Use proton pump inhibitor ( Nexium , Prilosec ) substantially increase stomach pH . Stool sample occult blood baseline exam</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Influenza</keyword>
	<keyword>pandemic</keyword>
	<keyword>avian influenza</keyword>
	<keyword>H5N1</keyword>
	<keyword>flu</keyword>
</DOC>